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Effects of subtherapeutic concentrations of antimicrobials on gene
acquisition events in Yersinia, Proteus, Shigella, and Salmonella recipient
organisms in isolated ligated intestinal loops of swine
Abstract
Objective—To assess antimicrobial resistance and transfer of virulence genes facilitated by subtherapeutic
concentrations of antimicrobials in swine intestines.
Animals—20 anesthetized pigs experimentally inoculated with donor and recipient bacteria.
Procedures—4 recipient pathogenic bacteria (Salmonella enterica serotype Typhimurium, Yersinia
enterocolitica, Shigella flexneri, or Proteus mirabilis) were incubated with donor bacteria in the presence of
subinhibitory concentrations of 1 of 16 antimicrobials in isolated ligated intestinal loops in swine. Donor
Escherichia coli contained transferrable antimicrobial resistance or virulence genes. After coincubations,
intestinal contents were removed and assessed for pathogens that acquired new antimicrobial resistance or
virulence genes following exposure to the subtherapeutic concentrations of antimicrobials.
Results—3 antimicrobials (apramycin, lincomycin, and neomycin) enhanced transfer of an antimicrobial
resistance plasmid from commensal E coli organisms to Yersinia and Proteus organisms, whereas 7
antimicrobials (florfenicol, hygromycin, penicillin G, roxarsone, sulfamethazine, tetracycline, and tylosin)
exacerbated transfer of an integron (Salmonella genomic island 1) from Salmonella organisms to Yersinia
organisms. Sulfamethazine induced the transfer of Salmonella pathogenicity island 1 from pathogenic to
nonpathogenic Salmonella organisms. Six antimicrobials (bacitracin, carbadox, erythromycin, sulfathiazole,
tiamulin, and virginiamycin) did not mediate any transfer events. Sulfamethazine was the only antimicrobial
implicated in 2 types of transfer events.
Conclusions and Clinical Relevance—10 of 16 antimicrobials at subinhibitory or subtherapeutic
concentrations augmented specific antimicrobial resistance or transfer of virulence genes into pathogenic
bacteria in isolated intestinal loops in swine. Use of subtherapeutic antimicrobials in animal feed may be
associated with unwanted collateral effects.
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Effects of subtherapeutic concentrations 
of antimicrobials on gene acquisition events 
in Yersinia, Proteus, Shigella, and Salmonella 
recipient organisms in isolated ligated intestinal 
loops of swine 
Matt T. Brewer, DVM; Nalee Xiong, Ph D; Kristi L. Anderson, DVM; Steve A. Carlson, DVM, Ph D 
Objective-To assess ant imicrobial res is tance and transfer of virulence genes faci litated by 
subthe rapeutic conce nt rat ions of antimicrobials in swine intestines. 
Animals-20 anesthetized pigs experimentally inoculated with donor and recip ient bacteria. 
Procedures-4 recipient pathogen ic bacteria (Salmonella enterica serotype Typhim urium, 
Yersinia enterocolitica, Shigella flexneri, or Proteus mirabilis) were incubated w ith donor 
bacteria in the presence of subinhi bito ry concentrations of 1 of 16 ant imicrobials in isolated 
ligated intestinal loops in swine. Donor Escherichia coli contained transferrable antimicrobial . 
resistance or virulence genes. After co incubations, intestinal contents were removed and 
assessed fo r pathogens that acquired new ant imicrobial resis tance or virulence genes fol-
lowing exposure to the subtherapeutic concentrati ons of antimicro bials. 
Results-3 antimicrob ials (ap ramycin, lincomycin , and neomycin) enhanced tra nsfer of an 
antimicrobial resistance plasmid from commensal E coli organisms to Yersinia and Prote-
us organisms, whereas 7 antimicrobials (florfenico l, hygromycin, pen ici llin G, roxa rsone, 
sulfamethazine, tet racycl ine, and tylos in) exacerbated t ransfer of an integ ron (Salmonella 
genomic island 1) from Salmonella organisms to Yersinia organisms. Sulfamethazine in-
duced the transfe r of Salmonella pathogenicity island 1 from pathogenic to nonpathogenic 
Salmonella organisms. Six a ntimicrobials (bacitracin, carbadox, erythromycin, s ulfathiazole, 
t iamu lin, and virginiamycin) did not mediate any transfe r events. Su lfamet hazic1e was the 
on ly antimicrobial implicated in 2 types of t ransfer events. 
Conclusions and Clinical Relevance-10 of 16 antimicrobials at s ubinhibi tory or subthera-
peutic concentrations augmented specific ant im icrobial resistance or transfer of viru lence 
genes into pathogenic bacteria in isolated intestina l loops in swine. Use of subtherapeutic 
antim icrobials in an ima l feed may be assoc iated with unwanted co llateral effects . (Am J Vet 
Res 2013;74 1078-1083) 
S u bth erapeutic con cen tra tions of antimicrobials have been used for decades as growth promotants and 
prophylactic agents. This practice has been scrutin ized 
as a contributor to th e d isseminatio n of antimicrobial 
resistance. Speci fi cally, subtherapeu tic concentrations 
of chlortetracycline have been associated w ith an in -
crease in resistance to m ultiple antimicrob ials for swine 
intestinal m icrobes. 1 Another study2 revealed that sub-
therapeutic con centra tions of antimicrobials can lead to 
the propaga tion of an timicrobial-resistant Enterococcus 
ESBL 
SGl1 
SPl1 
XLD 
ABBREVIATIONS 
Extend ed-s pectrum ~- l acta mase 
Salmonella ge nomic isl a nd 1 
Salm onella path oge ni city isl a nd 1 
Xylos e lys ine d eoxycholate 
organisms in swine. A recent study3 indica ted that in-
testinal bacteriophages are ac tivated by subtherapeutic 
concentra tions of antim icrobials, and th is activation 
can lead to transfer of antimicrobial resistance genes. 
However, these studies have not addressed specific gene 
transfer events that precipita te resistance and viru lence. 
Th us, li ttle is known abou t the e ffects of these antimi-
crobials on specific gene transfer even ts that promote 
the dissem ination of antim icrobial resistance and viru-
lence genes in en teri c path ogens. 
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The objective of the study reported here was to 
iden tify antimicrobials tha t at subtherapeutic concen-
trations augment the transfer of certain antimicrobial 
resistan ce and virulence genes. The main goal was to 
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assess 3 types of transfer events (plasmid transfer, inte-
gron transfer, and horizontal transfer of a pathogenicity 
island) mediated by subtherapeutic concentrations of 
antimicrobials in vivo. Specifically, the study was con-
ducted to determine the relative rates of antimicrobial-
mediated transfer events involving 3 representative anti-
microbial resistance plasmids, 1 model integron, and 1 
pathogenicity island in the presence of antimicrobials 
that have been approved for use (currently or in the 
past) at subtherapeutic concentrations as feed additives 
for swine. 
Materials and Met hods 
Animals- Twenty juvenile swine were used to as-
sess in vivo transfer events . Pigs were of mixed breeds 
and both sexes; pigs weighed between 5 and 10 kg. Ani-
mal experiments were approved by the Iowa State Uni-
versity Institutional Animal Care and Use Committee. 
Pigs were anesthetized with pentobarbitala ( 40 mg/ 
kg, intraperitoneal) . Isolated ligated loops of intestine 
(9 loops/pig; each ligated loop was 10 cm in length) 
were created4 with 2-0 silk sutures.b At the end of the 
experiments, anesthetized pigs were euthanized by 
intracardiac administration of an overdose of pentobar-
bital (100 mg/kg). 
Plasmid transfer- To determine plasmid trans-
fer from donor bacteria to recipient pathogenic bacte-
ria, each loop was injected with approximately 109 to 
10 11 CFUs of donor bacteria and 109 CFUs of recip ient 
bacteria in 1 ml of saline (O. 9% NaCl) solution that 
contained 1 of 16 feed additive antimicrobials< (apra-
mycin, bacitracin, carbadox, erythromycin, norfeni-
col, hygromycin, lincomycin, neomycin, penicill in G, 
roxarsone, sulfamethazine, sulfathiazole, tetracycline, 
tiamulin, tylosin, and virginiamycin); antimicrobial-
free saline solution was used as a negative control treat-
ment. Concentration of each antimicrobial was 1 µg/ 
ml. This concentration was chosen because it was less 
than the established breakpoints for all of the antimi-
crobial-bacteria combinations,5 and preliminary experi-
ments conducted by our laboratory group on the mini-
mum inhibitory concentration of these antimicrobials 
revealed that this was the lowest common concentration 
that permitted growth of all donor and recipient bacteria 
for each of the 16 antimicrobials (data not shown). 
Plasmid transfer from a donor commensal intesti-
nal Escherichia coli6 (antimicrobial susceptible and lack-
ing virulence genes) to each of 4 recipient pathogenic 
bacteria (Sa lmonella enterica serotype Typhimurium 
strain Sll344,7 Yersinia enterocolitica,d Shigellaflexneri,' 
or Proteus mirabilisr) was measured. All of the recipi-
ent bacteria were susceptible to most antimicrobials 
(except tetracycline and streptomycin), as determined 
by use of microdilution broth assays performed in ac-
cordance with standards established by the Clinical and 
Laboratory Standards Institute. 5 The E coli donor strain 
was experimentally transformed with 1 of 3 conjuga-
tive plasmids encoding an ESBL,8 amikacin resistance 
(aacC4), 9 or fluoroquinolone resistance (via the qnr 
gene). 10 
Bacteria were allowed to incubate in the isolated 
ligated intestinal loops for 1 hour, after which loops 
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were excised. Total volume of intestinal content in each 
iso lated loop was 1.1 to 1.2 ml; approximately 10% of 
the total content of each loop was removed for plating 
on media selective for each of the 4 pathogens (XLD 
agarg for Salmonella and Shigella organisms, Yersinia 
selective agar base11 for Yersinia organisms, and phenyl-
alanine agar& for Proteus organisms); agar contained 1 
of 3 antimicrobials (ceftiofur,; 32 µg/ml for the ESBL 
plasmid; amikacin,< 64 µg/ml; or enronoxacin,i 8 µg/ 
ml) at their respective breakpoint concentrations. 5 The 
content of each loop was cultered in triplicate (3 agar 
plates/loop). Control experiments revealed that the do-
nor E coli did not grow on the selective media, except 
for the XLD agar; however, the E coli colonies that grew 
on XLD agar were biochemically distinct from the Sal-
monella and Shigella colonies. 
Plates were incubated at 3 7°C for 16 hours. Bacte-
ria were then enumerated, and the number of translo-
cants/109 recipients was calculated by multiplying the 
number of recovered colonies by 10 to account for the 
fact that only 10% of the intestinal contents were plat-
ed. The log 10 of the product was derived and used for 
final data analysis and statistical evaluation. 
Transfer of the ESBL plasmid was assessed with a 
PCR assay with primers (5'-ATGATGAAAAAATCGT-
TATGCT-3' and 5'-TTATTGCAGCTTTTCAAGAAT-3') 
specific to the blacMr-z gene present on the ESBL plas-
mid.8 Each transfer event was determined for 100 rep-
resentative colonies. 
SGil transfer-The possibility that subinhibito-
ry concentrations of antimicrobials can modulate the 
transfer of SGll from Salmonella organisms to Yersinia 
recipients , Shigella recipients, or Proteus recipients was 
evaluated. The SG ll is a multi resistance integron that 
encodes resistance to 5 antimicrobials in Salmonella or-
ganismsn lntegrons are mobile genomic elements pu-
tatively transferred by bacterioµhages, 12 and studies13- 15 
have indicated that Yersinia spp, Shigella spp, and Pro-
teus spp are capable of receiving integrons. 
To evaluate SGil transfer, approximately 109 CFUs 
of SGil-free recipient (Yersinia enterocolitica, Shigella 
flexneri, or Proteus mirabilis [all of which were sus-
ceptible to most antimicrobials, except tetracycline 
and streptomycin, as determined with microdilution 
broth assays performed in accordance with standards 
established by the Clinical and Laboratory Standards 
Institute5 ]) were each coinoculated with 109 CFUs of 
SGil-bearing donor S enterica serotype Typhimurium 
phagetype DT104 strain LNWI4 into ligated intestinal 
loops. Coincubations included 1 of the 16 aforemen-
tioned antimicrobials (concentration, 1 µglml) and the 
negative control treatment (saline solution without an 
antimicrobial)_ 
Bacteria were allowed to incubate in the isolated li-
gated intestinal loops for 1 hour, after which loops were 
excised. Total volume of the intestinal content in each 
isolated loop was 1.1to1.2 ml; approximately 10% of 
the total content of each loop was removed for plating 
on media selective for each of the 3 pathogens (XLD 
agar for Salmonella and Shigella organisms, Yersinia se-
lective agar base for Yersinia organisms, and phenylala-
nine agar for Proteus organisms); agar contained 1 of 
2 antimicrobials relevant for SGil (ampicillin,< 32 µg/ 
1079 
mL; chloramphenicol,' 32 µglmL) at their respective 
breakpoint concentrations. 5 The content of each loop 
was cultured in triplicate (3 agar plates/loop). 
Plates were incubated at 3 7°C for 16 hours. Bacte-
ria then were enumerated, and the number of translo-
cants/109 recipients was calculated by multiplying the 
number of recovered colonies by 10 to account for the 
fact that only 10% of the intestinal contents were plat-
ed. The log
10 
of the product was derived and used for 
final data analysis and statistical evaluation. 
A PCR assay specific to the jloR-tetR sequence in 
SGil 16 was used to assess the presence of the SGil inte-
gron in 100 representative recipient bacteria that grew 
on selective media containing ampicillin and chloram-
phenicol. Additionally, transferrants were assessed for 
the absence of a Salmonella virulence gene segment 
(si pBIC) .16 Control experiments revealed that the donor 
Salmonella organisms were not able to grow on the me-
dia selective for Yersinia spp and Proteus spp, whereas 
Salmonella organisms were distinguishable from Shi-
gel la organisms on XLD agar. 
SPil transfer-Transfer of SPil from pathogenic 
to nonpathogenic Salmonella organisms was evaluated. 
The SPil is a major determinant of virulence in Sal-
monella organisms, and avirulent Salmonella organisms 
lack SPil. 17 The genomic structure of SPil suggests that 
this island is transferrable .18 In vivo coincubations with 
the 16 antimicrobials and the negative control treat-
ment (saline solution without an antimicrobial) were 
perfo rmed as described previously for the plasmid and 
integron transfer experiments . The SPil-bearing S en-
terica serotype Typhimurium (antimicrobial-suscepti-
ble strain SL13447) was incubated with 1 of 4 SPil-free 
strains (S enterica sero types Litchfield , 17 Senftenberg, 17 
Seminole, or Betiocky), all 4 of which were transformed 
with a nonco njugative plasmid encoding green fluores-
cent protein. 19 For this experiment, 1011 CFUs of donor 
bacteria and 1011 CFUs of recipient bacteria were used 
for the incubations. 
Bacteria were allowed to incubate in the ligated 
loops for 1 hour. Total volume of each loop was 1.1 
to 1.2 mL; approximately 10% of the total content of 
each loop was rem oved and used in a large-volume tis-
sue culture invasion assay20 in which recovered bacteria 
were plated on XLD agar that contained 50 µ g of zeo-
cink/mL (zeocin is the selective marker for the fluores-
cence plasmid19). The content of each loop was cultured 
in triplicate (3 agar plates/loop). Fluorescent colonies 
that were invasive (ie, recovered from inside tissue cul-
ture cells) were individually expanded in fresh nutrient 
b roth and then subjected to a second invasion assay. 
Amount of invasion was compared with that of strain 
SL1344. 7 Serotype analysis was conducted at another 
laboratory,1 and a PCR assay that detected the sipB-
sipC sequence in SPil 16 was performed on each clone 
for which invasion was indistinguishable from that of 
strain SL1344 (approx 1 % invasion). 
Statistical analysis-Statistical differences were 
assessed with an ANOVA.m There were 51 combina-
tions of antimicrobials and transfer events ( [ 16 anti-
microbials plus 1 antimicrobial-free treatment] times 
3 transfer events), each assessed in 3 separate ligated 
1080 
loops (153 total loops) and 3 agar plates/loop (459 to-
tal loops). Frequency data for all transfer events were 
analyzed en masse to allow for interantimicrobial and 
intraevent comparisons and intra-antimicrobial and 
interevent comparisons (ie, comparisons were made 
among the antimicrobials within the 3 transfer events 
[plasmid, SGil, and SPil] and among the 3 transfer 
events within a specific antimicrobial). The Scheffe F 
test was chosen as the ad hoc test because our research 
group has empirically found it to be the most conserva-
tive for detecting differences , in contrast to the Bonfer-
roni test. Values of P < 0.05 were considered significant. 
Results 
Plasmid transfer-In vivo trans fer events of 3 
clinically relevant antimicrobial resistance plasmids 
were assessed by use of ligated intestinal loops of 
swine. Loops were coinoculated with donor commensal 
E coli bearing 1 of 3 antimicrobial resistance plasmids, 
1 of 4 recipient pathogenic Enterobacteriaceae, and an 
antimicrobial (1 µglmL) approved as a feed additive in 
swine. Commensal E coli. and recipient Enterobacte-
riaceae were chosen because these microbes are highly 
representative of enteric bacteria that transfer genetic 
information. Three antimicrobials mediated a signifi-
cant increase in the frequency of a specific plasmid 
transfer event in vivo (Figure 1). An increased frequen-
cy of transfer of the ESBL plasmid from E coli to Yer-
sinia recipients and from E coli to Proteus recipients was 
evident in the presence of apramycin, lincomycin, or 
neomycin (Table 1). None of the antimicrobials caused 
significant changes in the frequencies of ESBL plasmid 
transfer from E coli to Salmonella recipients and from 
E coli to Shigella recipients . Additionally, none of the 
antimicrobials caused significant changes in transfer of 
amikacin resistance plasmids or fluoroquinolone resis-
tance plasmids . 
Yersinia onterocolilica Proteus mirobilis 
Recipient bacteria 
Figu re 1-Plasmid transfer from commensal Escherichia coli to 
Yersinia organisms and Proteus organisms after co incubation 
with a subtherapeutic concentration (1 µg/mU of lincomycin 
(white bars), apramycin (gray bars). or neomycin (striped ba rs) or 
with sa line (0.9% NaCl) solution that did not contain an antimicro-
bial (negative contro l treatment [b lack bars]) for 1 hour in isolated 
ligated intestinal loops in swine. Results represe nt the mean ± 
SEM for 3 experiments that were each performed in triplicate. 
Notice that there was enhancement of transfer of the ESB L plas-
mid8 in the presence of subtherapeutic concentrations of anti-
microbials in Yersinia recipients and Proteus recipients. *Within a 
bacterium, value differs significantly (P < 0.05) from the value for 
the negative control treatment 
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Table 1-Gene transfer events for donor bacteria to recipient bacteria after coincubation with a subtherapeutic concentration (1 µg/ml) 
of 16 antimicrobials or saline (0 .9 % NaCl) solution that did not contain an antimicrobial (negative control treatment) for 1 hour in isolated 
ligated intestinal loops in swine. 
Antimicrobial 
Saline so lution 
Apramycin 
Bacitracin 
Carbadox 
Erythromycin 
Florfenicol 
Hygromycin 
Lincomycin 
Neomycin 
Penicillin G 
Roxarsone 
Sulfamethazine 
Sulfathiazole 
Tetracycline 
Tiamulin 
Tylosin 
Virginiamycin 
ESBL plasmid transfer 
NA 
Yersinia and Proteus recipients* 
Yersinia and Proteus recipients* 
Yersinia and Proteus recipients* 
SGl1 transfer 
NA 
Yersinia recipients* 
Yersinia recipients* 
Yersinia recipients* 
Yersinia recipients* 
Yersinia recipients* 
Yersinia recipients* 
Yersinia recipients* 
SPl1 transfer 
NA 
3 recipient nonpathogenic 
serovars of Salmonella enterica*t 
Ratio of 
total transfer 
frequencies 
1.0 
3,471 
2.3 
0.6 
0.7 
9.8 
5.1 
4,596 
4,641 
4.4 
4.7 
13.6 
1.1 
4.1 
1.2 
10.3 
0.9 
Mean transfer frequency in the absence of an antimicrobial was approximately 1.4 X 10-a transconjugates/recipient for the ESBL plasmid, 
2.6 X 10-• translocants/recipient for SGll, and 3 X 10-11 invasive clones/noninvasive rec ipient for SPl1; these frequencies were calculated by 
dividing the total number of all recovered recipients by the total number of donor bacteria added to all of the coincubations in the absence of an 
antimicrobial. For each antimicrobial, the ratio of total transfer frequencies= (total number of all bacteria that received the new genetic element 
when coincubated with an antimicrobial/total number of recipients coincubated with an antimicrobial)/(total number of all bacteria that received 
the new genetic element when coincubated without an antimicrobial/tota l number of recipients coincubated without an antimicrobia l). 
*Transfer frequency was significantly (P < 0.05) greater than the transfer frequency for the antimicrobial-free (negative control) treatment. 
t Salmonella enterica serotypes Betiocky, Li tc hfield, and Seminole. 
NA= Not applicable. - =Transfer frequency was not significantly greater than the transfer frequency for the antimicrobial-free (negative 
control) treatment. 
The PCR assay of 100 representative 
ceftiofur-resistant colonies from each of 
the aforementioned transfer events re-
vealed that 96% to 97% of the putative 
transconjugates contained blacM1, 2 . Colo-
nies that lacked this sequence were nu-
merically discounted as transconjugates 
in the final calculations (Figure 1). 
SGil transfer-In vivo transfer events 
2 
Jij 
c:: 
., 
·15. 
-~ 
~ 
* T 
* 
* 
* 
T * 
0 of an integron were assessed with ligated o 
intestinal loops coinoculated with donor ! 
Salmonella organisms bearing SGll ,11 1 of 
4 recipient pathogenic Enterobacteriaceae, 
and an antimicrobial (1 µglmL) approved 
as a feed additive in swine. Seven antimicro-
bials mediated a significant increase in the 
frequency of in vivo transfer of a specific in-
tegron (Figure 2) . An increased frequency of 
transfer of the SGll integron from Salmonel-
la organisms to Yersinia organisms was evi-
dent in the presence of florfenicol, hygromy-
cin, penicillin G, roxarsone, sulfamethazine, 
tetracycline, and tylosin (Table 1). None of 
the antimicrobials caused significant chang-
es in the frequencies of SGil transfer events 
from Salmonella organisms to either of the 
other 2 pathogens examined. The PCR assay 
0 -, 
Figure 2-Transfer of SGl1 from Salmonella enterica serotype Typhimurium phage-
type DT104 to Yersinia enterocolitica after coincubation w ith a subtherapeutic con-
centration (1 µg/ml) of 16 antimicrobials or saline solution that did not contain an 
antimicrobial (negative control treatment) for 1 hour in isolated ligated intestinal 
loops in swine. Results represent the mean ± SEM for 3 experiments that were 
each performed in triplicate. Notice that transfer of the integron was enhanced in 
the presence of 7 antimicrobials. *Value differs significantly (P < 0.05) from the 
value for coincubation with the negative control treatment. SMZ = Sulfamethazine. 
of 100 representative colonies from each of the 16 afore-
mentioned transfer events revealed that 98% to 99% of the 
putative SGil recipients contained the floR-tetR sequence 
indicative of SGll. 16 Colonies that lacked this sequence 
were numerically discounted as translocants in the final 
calculations. 
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Figure 3-Transfer of SPI 1 from pathogenic Salmonella organ-
isms to nonpathogenic Salmonella organisms after coincubation 
with a subtherapeutic concentration (1 µg/ml) of sulfamethazine 
(white bars) or saline solution that did not contain an antimicro-
bial (negative contro l treatment [black bars]) for 1 hour in isolated 
ligated intestinal loops in swine. Fluorescent bacteria were sub-
jected to 2 invasion assays, and colonies that were invasive (ie, 
recovered from inside tissue culture cells) were quantitated by 
enumerating the bacteria recovered from tissue culture cell ly-
sates at the end of the second assay. Invasion represents the 
percentage as compared with that of the donor Salmonella or-
ganisms. Results represent the mean ± SEM for 3 experiments 
that were each performed in triplicate. Notice that transfer of 
SPl1 was only detected in the presence of sulfamethazine and 
that 1 clone of S enterica serotype Litchfield was invasive in the 
absence of an antimicrob ia l. The number above each column indi-
ca tes the cumulative number of serovar-specific clones that were 
invasive across 3 separate experiments. 
SPil transfer-In vivo transfer events of a patho-
genicity island were assessed with ligated intestinal 
loops coinoculated with donor Salmonella organisms, 1 
of 4 recipient nonpathogenic Salmonella organisms that 
lacked SPil, and an antimicrobial (1 µglmL) approved 
as a feed additive in swine. Sulfamethazine mediated the 
horizontal transfer of SPil in vivo (Figure 3). Three of 
4 SPil-free S enterica serovars (Betiocky, Seminole, and 
Litchfield) had transfer events in the presence of sulfa-
methazine (Table 1) . Transfer of SPil was detected in 
the absence of an antimicrobial for 1 clone of S enterica 
serovar Litchfield . Salmonella enterica serovar 5enften-
berg did not acquire SPil in this experiment. Results of 
the PCR assays confirmed the presence of the sipB-sipC 
genomic segment in all clones that had invasion indis-
tinguishable from that of strain SL1344. 
Discussion 
The use of subtherapeutic concentrations of anti-
microbials in livestock feed is a controversial practice 
that is being scrutinized. Of concern are the unknown 
collateral effects on bacterial gene transcription, plas-
mid transconjugation from commensals to patho-
gens, and viral-mediated transduction of genes from 
commensals to pathogens and from one pathogen to 
another. Specifically, these collateral effects can acti-
vate molecular processes culminating in gene transfer 
events that yield pathogens with multiple antimicrobial 
resistance or pathogens with new virulence capabilities. 
The experiments in the present study involved the 
use of a low concentration (1 µglmL) of antimicrobials 
1082 
to mimic field conditions without directly harming the 
donor or recipient bacteria. Although this concentra-
tion may be lower than concentrations in the intesti-
nal tract of swine fed feed that contains antimicrobials, 
this concentration was considered relevant for swine in 
which the antimicrobial is removed from the diet prior 
to slaughter. 
The present study revealed that there were transfer 
events in the absence of an antimicrobial and that cer-
tain antimicrobials mediated gene transfer events at a 
higher frequency than did other antimicrobials (Table 
1). Sulfamethazine mediated 2 separate transfer events 
(5Gll transfer and 5Pll transfer) , whereas a related 
drug, sulfathiazole, did not mediate any transfer events. 
Bacitracin, carbadox, erythromycin, tiamulin, and vir-
giniamycin were also not implicated in transfer events. 
Transfer events were confirmed with a PCR assay, al-
though a few (1 % to 4%) transconjugates and translo-
cants did not harbor the transferrable element, which 
suggested that efflux systems may have been activated 
in these few clones. 
Three classes of antimicrobials were implicated in 
transfer of the ESBL plasmid. Lincomycin is a lincos-
amide , apramycin is an aminocyclitol, and neomycin is 
an aminoglycoside (although the latter 2 are sometimes 
grouped in the same class). Lincomycin is an inhibitor 
of the 50S ribosome in bacteria, yet 3 other 50S inhibi-
tors (erythromycin, tiamulin , and virginiamycin) did 
not mediate transfer events. Apramycin and neomycin 
are inhibitors of the 305 ribosome, but another 30S in-
hibitor, tetracycline, did not exacerbate transfer of the 
ESBL plasmid. It is possible that apramycin, lincomy-
cin, and neomycin can selectively alter protein synthe-
sis that impacts sex pheromones and conjugation . 
Seven antimicrobials (florfenicol, hygromycin , 
penicillin G, roxarsone, sulfamethazine, tetracycline, 
and tylosin) from 7 antimicrobial classes were impli-
cated in the transfer of SGIL Tylosin and florfenicol 
are 505 inhibitors, but that is the extent of the similari-
ties among these 7 antimicrobials. Because movement 
of SGil may be a phage-mediated event, 12 it is possible 
that those 7 antimicrobials activated phage recrudes-
cense in 5Gll-bearing Salmonella organisms, similar 
to that recently reported for sulfamethazine, chlortet-
racycline, and penicillin. 3 It is also possible that naked 
SGil DNA was transferred from Salmonella organisms 
to Yersinia organisms, although to our knowledge this 
process has not been described in the literature. 
Analysis of results of the present study indicated 
that certain antimicrobials at subtherapeutic concentra-
tions are more likely to mediate unwanted gene trans-
fer into pathogenic bacteria in ligated intestinal loops 
in swine. Sulfamethazine mediated 2 types of transfer, 
whereas apramycin, lincomycin, and neomycin exerted 
the greatest quantitative effect on a single transfer event 
into 2 genera of Enterobacteriaceae. Bacitracin, carbadox, 
erythromycin, sulfathiazole, tiamulin, and virginiamycin 
did not significantly influence any of the 3 transfer events 
evaluated. No antimicrobial class-specific patterns were 
observed in the 3 transfer events. Transfer of the ESBL 
plasmid was detected at the highest frequency Protein 
synthesis irregularities may underlie transfer of the E5BL 
plasmid, and activation ofbacteriophages may be involved 
AJVR, Vol 74, No. 8, August 2013 
in SGil transfer or SPil transfer (or both). Regardless of 
the mechanisms involved, subtherapeutic concentrations 
of antimicrobials have potential ecologic impacts that in-
volve the dissemination of antimicrobial resistance and 
virulence genes. 
a. Fon Dodge Animal Health , Fort Dodge, Iowa. 
b. Ethicon Inc, Somerville, NJ. 
c. Sigma Chemical Co, St Louis, Mo. 
cl. Yersinia enterocolitica 9610, ATCC, Manassas, Va. 
e. Shigella flexn eri 9199, ATCC, Manassas, Va. 
f. Proteus mirabilis 4630, ATCC, Manassas, Va. 
g. Becton Dickinson, Franklin Lakes , NJ. 
h. Thermo Fisher Scientific, Pittsburgh, Pa. 
i. Pfizer Inc, Kalamazoo, Mich. 
j. Bayer Corp, Shawnee Mission, Kan. 
k. Invitrogen Corp, Carlsbad, Calif. 
I. National Veterinary Service Laboratories , Ames, Iowa. 
m. StatView, version 2, SAS Institute Inc, Cary, NC. 
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